» Articles » PMID: 19429053

Delayed Peripheral Administration of the N-terminal Tripeptide of IGF-1 (GPE) Reduces Brain Damage Following Microsphere Induced Embolic Damage in Young Adult and Aged Rats

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2009 May 12
PMID 19429053
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously reported that peripheral administration of GPE prevents neuronal injury after ischemic reperfusion injury in young adult rats. This study examined the ameliorating effects of GPE-treatment after embolic injury induced by microsphere injection in young adult and aged male rats. Unilateral injury was induced by injecting microspheres into the right internal carotid artery in both young adult (3-4 months) and aged (16-17 months) male rats. Either GPE (12mg/kg) or the vehicle was infused intravenously over 1h starting 3h after embolic injury and the degree of brain injury, astrocytosis and vascular remodeling were examined using histological and immunohistochemical analysis 8 days later. Changes in core temperature, blood glucose concentration, oxygen saturation and heart rate were monitored. Microsphere injection induced multiple sites of focal damage in the ipsilateral subcortical regions. Massive numbers of microglia accumulated within the core of the tissue damage whereas astrocytes were located in the penumbra. There was no difference in the degree of brain injury between the young and aged control rats. However the aged rats showed less injury-induced astrocytosis and greater vascular remodeling. Intravenous infusion of GPE 3h after the injury reduced overall damage scores in both young (p<0.01) and aged rats (p<0.05). GPE-treatment reduced astrocytosis in young, but not aged animals and did not significantly alter the vascular remodeling in either age group. The data suggested that the neuroprotection of the tripeptide is independent of cerebral reperfusion and is not age selective.

Citing Articles

Neural Influences on Tumor Progression Within the Central Nervous System.

Lv W, Wang Y CNS Neurosci Ther. 2024; 30(10):e70097.

PMID: 39469896 PMC: 11519750. DOI: 10.1111/cns.70097.


Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions.

Guan J, Li F, Kang D, Anderson T, Pitcher T, Dalrymple-Alford J Molecules. 2023; 28(3).

PMID: 36770687 PMC: 9919809. DOI: 10.3390/molecules28031021.


Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences.

Silva-Reis S, Sampaio-Dias I, Costa V, Correia X, Costa-Almeida H, Garcia-Mera X ACS Chem Neurosci. 2023; 14(4):554-572.

PMID: 36735764 PMC: 9936549. DOI: 10.1021/acschemneuro.2c00675.


Role of microglia under cardiac and cerebral ischemia/reperfusion (I/R) injury.

Surinkaew P, Sawaddiruk P, Apaijai N, Chattipakorn N, Chattipakorn S Metab Brain Dis. 2018; 33(4):1019-1030.

PMID: 29656335 DOI: 10.1007/s11011-018-0232-4.


GPE Promotes the Proliferation and Migration of Mouse Embryonic Neural Stem Cells and Their Progeny In Vitro.

Almenglo C, Devesa P, Devesa J, Arce V Int J Mol Sci. 2017; 18(6).

PMID: 28621713 PMC: 5486102. DOI: 10.3390/ijms18061280.